Cancer treatments, despite their transformative potential, often come with unintended cardiovascular risks. Cardio-oncology focuses on understanding and mitigating these risks through a combination of cutting-edge diagnostics and personalized care. By using technologies like cardiac MRI and strain imaging, clinicians can detect early signs of heart stress caused by therapies such as radiation or targeted treatments. This collaborative field not only emphasizes prevention but also explores innovative therapeutics to repair heart damage. As survival rates improve, the integration of cardio-oncology ensures long-term health, enabling patients to overcome cancer without compromising cardiovascular wellness.
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27 year old man
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina